About William Resides
Form D filings for BioRegenx from 2021 to 2024 list William Resides as CEO, Interim CFO and director.
William Resides reports to the SEC as a director, officer or major shareholder of 1 public company.
William Resides first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name William Resides in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people William Resides works with at each company, as listed on that company's latest Form D.
BioRegenx Inc. · Form D, Apr 4, 2023
JB
Joseph Bird
Promoter
RD
Robert Doran
Promoter
SA
Sherri Adams
Director
SB
Suzanne Bird
Director
HV
Hans Vink
Executive officer, director and promoter
RL
Robert Long
Executive officer, director and promoter
JW
Jody Walker
Director
GH
Gary Hennerberg
Executive officer and director
HJ
Hitesh Juneja
Executive officer